| In-house lobbyists who participated in the lobbying activity: |
Kim Steele
|
|
Senior Public Office Holders who were lobbied in this activity:
|
Tijana Fazlagic,
Executive Director, PharmaCare Benefits Branch
Health
Footnote1
|
| |
Subject Matter of the Lobbying Activity
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
We are calling on the BC government to ensure that CF modulator and symptom management drugs are available to all who need them. In particular, we will be calling on the BC government to fund Trikafta immediately upon Health Canada approval with the broadest prescribing criteria for those diagnosed with cystic fibrosis from age 6 plus.
|
- Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
|
| |
|
Senior officer who filed this Lobbying Activity Report:
|
Kelly Grover
|
| |
|
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
|
| |
-
Indicates new information that was added through a Lobbying Activity Report.
|